Compare StocksINTU vs MRNA

Intuit Inc. (INTU) vs Moderna, Inc. (MRNA): Which Is the Better Buy in 2026?

As of 2026-06-19, INTU is undervalued at $267, with a DCF intrinsic value of $536 and a margin of safety of 50%. MRNA is overvalued at $64, with an intrinsic value of $6 and a margin of safety of -963%. Of the two, INTU has the wider margin of safety.

INTU
Intuit Inc.
$267.00
VS
MRNA
Moderna, Inc.
$63.96

Rewards

INTU
  • Gross margin of 80.8% indicates strong pricing power — typical of businesses with significant intellectual property or brand strength.
  • Intuit Inc. scores 79/100 on the Economic Moat Score (Wide Moat), with revenue predictability as the strongest competitive dimension.
  • Free cash flow has grown at a 18.5% CAGR over the past 4 years, demonstrating strong earnings power growth.
MRNA

    Risks

    INTU
    • FCF yield of 7.2% suggests reasonable valuation assuming continued moderate growth.
    MRNA
    • ROIC has declined by 67.4 percentage points over the past 4 years, which may signal competitive erosion.
    • Gross margin of -69.9% is low, suggesting a competitive or commodity-like market with limited pricing power.
    • Moderna, Inc. scores only 17/100 on the Economic Moat Score, suggesting limited durable competitive advantages.

    Key Valuation Metrics

    Learn more →
    INTU
    MRNA
    Valuation
    $5.23B
    Free Cash Flow
    $-20.00M
    7.16%
    FCF Yield
    -0.08%
    16.30
    Trailing P/E
    N/A
    9.77
    Forward P/E
    -15.21
    Quality & Moat
    28.21%
    ROIC
    -26.47%
    22.50%
    ROE
    -36.56%
    80.79%
    Gross Margin
    -69.89%
    0.73
    PEG Ratio
    N/A
    Balance Sheet Safety
    0.01
    Net Debt / Equity
    Net cash
    N/A
    Interest Coverage
    N/A
    0.02
    Net Debt / EBITDA
    N/A
    1.71%
    Dividend Yield
    0.00%
    INTU: 6Ties: 1MRNA: 2
    INTUMRNA

    Historical Fundamentals

    Learn more →
    INTU

    Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

    MRNA

    Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

    Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

    $1 Retained Earnings Test

    Learn more →
    INTU
    $12.31
    created per $1 retained over 3 years
    Exceptional Value Creator
    Σ Retained
    $6.10B
    Δ Market Cap
    +$75.17B
    Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
    > $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer
    MRNA
    N/A
    Net losses over 3 years — test not applicable
    Company had negative cumulative retained earnings
    Σ Retained
    $-11.10B
    Δ Market Cap
    $-57.53B
    Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
    > $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

    Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
    > $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

    Discounted Cash Flow (DCF) Analysis

    Learn more →
    INTU
    50.2% Margin of Safety
    Price is 50.2% below estimated fair value
    Current Price: $267.00
    Fair Value: $535.61
    Strongly undervalued
    Undervalued
    Fairly valued
    Overvalued
    Strongly overvalued
    MRNA
    962.8% Overvalued
    Price is 962.8% above estimated fair value
    Current Price: $63.96
    Fair Value: $6.02
    Strongly undervalued
    Undervalued
    Fairly valued
    Overvalued
    Strongly overvalued

    Reverse DCF — Market-Implied Growth

    Learn more →
    INTU

    What growth rate is the market pricing in at $267?

    +4.7%
    Market-Implied Owner Earnings Growth
    Standard FCF implies +2.8%

    The market implies +4.7% Owner Earnings growth, below historical trends — potential opportunity.

    Standard FCF implies a more demanding +2.8%, reflecting heavy growth investment expected to generate future returns.

    MRNA

    Requires positive FCF to compute implied growth rate.

    Economic Moat Score

    Learn more →
    INTU
    79/100
    Wide Moat
    70+ Wide · 40-69 Narrow · <40 None

    Wide moat driven primarily by revenue predictability. ROIC Consistency is the area most vulnerable to competitive pressure.

    Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.
    MRNA
    17/100
    No Moat
    70+ Wide · 40-69 Narrow · <40 None

    No durable competitive advantage detected. The business shows limited evidence of pricing power, consistent returns, or capital efficiency.

    Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 5 years of fundamental data.

    Forensic Accounting

    Learn more →
    INTU
    -2.65
    Unlikely Manipulator
    Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

    M-Score Trend

    Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.
    MRNA

    Insufficient data for Beneish M-Score calculation (requires 2+ years).

    Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

    Ownership Breakdown

    Learn more →
    INTU
    Insiders 2.4%Institutions 92.3%Retail & Other 5.4%
    No. of Institutional Holders2,820
    High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.
    MRNA
    Insiders 7.3%Institutions 78.9%Retail & Other 13.7%
    No. of Institutional Holders1,044
    High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.

    High insider ownership aligns management incentives with shareholders. Institutional concentration can indicate smart-money conviction but also crowding risk.

    Insider Buying Activity

    Learn more →
    INTU
    1
    Buys (3M)
    1
    Buys (12M)
    Total value (12M): $541,665
    PRABHU VASANT M.
    Director
    $541,665
    @ $309.52 · 2026-05-26
    Open market purchases · includes direct & indirect ownership · excludes option exercises
    MRNA
    0
    Buys (3M)
    0
    Buys (12M)
    SAGAN PAUL L
    Director
    $1.00M
    @ $31.76 · 2025-03-03
    BANCEL STEPHANE J
    Chief Executive Officer
    $5.00M
    @ $31.22 · 2025-03-03
    Open market purchases · includes direct & indirect ownership · excludes option exercises

    Open market purchases · includes direct & indirect ownership · excludes option exercises.

    Insider Selling Activity

    Learn more →
    INTU
    1
    Sells (3M)
    16
    Sells (12M)
    Total value (12M): $11.47M
    DALZELL RICHARD L
    Director
    $289,448
    @ $288.29 · 2026-06-11
    DALZELL RICHARD L
    Director
    $457,046
    @ $457.50 · 2026-03-12
    AUJLA SANDEEP S
    Chief Financial Officer
    $840,097
    @ $629.76 · 2026-01-05
    AUJLA SANDEEP S
    Chief Financial Officer
    $741,172
    @ $675.02 · 2025-12-19
    DALZELL RICHARD L
    Director
    $219,763
    @ $659.95 · 2025-12-11
    DALZELL RICHARD L
    Director
    $435,354
    @ $653.68 · 2025-12-10
    AUJLA SANDEEP S
    Chief Financial Officer
    $792,160
    @ $677.06 · 2025-10-03
    DALZELL RICHARD L
    Director
    $665,951
    @ $666.62 · 2025-09-11
    AUJLA SANDEEP S
    Chief Financial Officer
    $27,930
    @ $665.00 · 2025-08-25
    DALZELL RICHARD L
    Director
    $255,887
    @ $768.43 · 2025-07-10
    DALZELL RICHARD L
    Director
    $521,891
    @ $783.62 · 2025-07-09
    BALAZS ALEX G
    Chief Technology Officer
    $689,400
    @ $782.52 · 2025-07-08
    AUJLA SANDEEP S
    Chief Financial Officer
    $2.03M
    @ $782.22 · 2025-07-03
    AUJLA SANDEEP S
    Chief Financial Officer
    $1.25M
    @ $773.90 · 2025-07-02
    NOTARAINNI MARK PHILLIP
    Officer
    $887,583
    @ $774.51 · 2025-07-02
    HOTZ LAUREN DALE
    Officer
    $1.36M
    @ $784.24 · 2025-06-27
    BALAZS ALEX G
    Chief Technology Officer
    $1.12M
    @ $771.24 · 2025-06-05
    TESSEL MARIANNA
    Officer
    $26.12M
    @ $760.84 · 2025-06-03
    FENNELL LAURA A
    Officer
    $19.29M
    @ $752.25 · 2025-05-29
    FENNELL LAURA A
    Officer
    $30.46M
    @ $738.61 · 2025-05-28
    AUJLA SANDEEP S
    Chief Financial Officer
    $11.66M
    @ $726.15 · 2025-05-27
    NOTARAINNI MARK PHILLIP
    Officer
    $340,143
    @ $725.25 · 2025-05-27
    MCLEAN KERRY JEAN
    General Counsel
    $12.18M
    @ $729.16 · 2025-05-27
    FENNELL LAURA A
    Officer
    $5.00M
    @ $612.45 · 2025-03-24
    TESSEL MARIANNA
    Officer
    $4.43M
    @ $600.13 · 2025-03-21
    BURTON EVE B
    Director
    $1.02M
    @ $600.00 · 2025-03-20
    HOTZ LAUREN DALE
    Officer
    $667,838
    @ $619.52 · 2025-01-10
    AUJLA SANDEEP S
    Chief Financial Officer
    $814,350
    @ $626.42 · 2025-01-08
    FENNELL LAURA A
    Officer
    $2.94M
    @ $613.70 · 2025-01-07
    AUJLA SANDEEP S
    Chief Financial Officer
    $68,506
    @ $628.50 · 2025-01-03
    NOTARAINNI MARK PHILLIP
    Officer
    $228,121
    @ $630.17 · 2025-01-03
    BALAZS ALEX G
    Chief Technology Officer
    $15.86M
    @ $665.98 · 2024-12-12
    FENNELL LAURA A
    Officer
    $5.06M
    @ $657.64 · 2024-12-10
    MCLEAN KERRY JEAN
    General Counsel
    $11.16M
    @ $650.78 · 2024-12-09
    Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives
    MRNA
    3
    Sells (3M)
    6
    Sells (12M)
    Total value (12M): $11.57M
    KLINGER SHANNON THYME
    Officer
    $173,550
    @ $50.00 · 2026-06-04
    HOGE STEPHEN
    President
    $2.58M
    @ $48.40 · 2026-05-15
    HUSSAIN SHAH ABBAS
    Director
    $264,952
    @ $46.63 · 2026-05-01
    KLINGER SHANNON THYME
    Officer
    $726,047
    @ $52.29 · 2026-03-02
    HOGE STEPHEN
    President
    $7.81M
    @ $48.84 · 2026-02-23
    HUSSAIN SHAH ABBAS
    Director
    $13,910
    @ $27.60 · 2025-12-09
    HUSSAIN SHAH ABBAS
    Director
    $8,736
    @ $28.00 · 2025-06-11
    KLINGER SHANNON THYME
    Officer
    $23,637
    @ $44.68 · 2024-12-09
    KLINGER SHANNON THYME
    Officer
    $4,849
    @ $43.29 · 2024-12-03
    HOGE STEPHEN
    President
    $13,595
    @ $43.30 · 2024-12-03
    KLINGER SHANNON THYME
    Officer
    $60,675
    @ $42.79 · 2024-11-29
    HOGE STEPHEN
    President
    $12,452
    @ $42.79 · 2024-11-29
    MOCK JAMES M
    Chief Financial Officer
    $60,761
    @ $42.79 · 2024-11-29
    HOGE STEPHEN
    President
    $12,771
    @ $46.10 · 2024-11-11
    MOCK JAMES M
    Chief Financial Officer
    $42,986
    @ $60.12 · 2024-10-07
    KLINGER SHANNON THYME
    Officer
    $40,539
    @ $73.57 · 2024-09-09
    KLINGER SHANNON THYME
    Officer
    $8,777
    @ $76.99 · 2024-09-03
    HOGE STEPHEN
    President
    $24,483
    @ $76.99 · 2024-09-03
    KLINGER SHANNON THYME
    Officer
    $12,640
    @ $78.02 · 2024-08-29
    HOGE STEPHEN
    President
    $23,408
    @ $78.03 · 2024-08-29
    MOCK JAMES M
    Chief Financial Officer
    $12,640
    @ $78.02 · 2024-08-29
    KLINGER SHANNON THYME
    Officer
    $104,722
    @ $79.39 · 2024-08-28
    MOCK JAMES M
    Chief Financial Officer
    $104,881
    @ $79.40 · 2024-08-28
    HOGE STEPHEN
    President
    $21,363
    @ $84.11 · 2024-08-12
    AFEYAN NOUBAR BOGHOS
    Director
    $1.80M
    @ $119.96 · 2024-07-31
    AFEYAN NOUBAR BOGHOS
    Director
    $1.77M
    @ $117.80 · 2024-07-24
    AFEYAN NOUBAR BOGHOS
    Director
    $1.84M
    @ $122.84 · 2024-07-17
    HOGE STEPHEN
    President
    $1.82M
    @ $121.12 · 2024-07-15
    AFEYAN NOUBAR BOGHOS
    Director
    $1.76M
    @ $117.08 · 2024-07-10
    MOCK JAMES M
    Chief Financial Officer
    $81,465
    @ $118.24 · 2024-07-08
    AFEYAN NOUBAR BOGHOS
    Director
    $1.91M
    @ $127.22 · 2024-06-26
    AFEYAN NOUBAR BOGHOS
    Director
    $2.00M
    @ $133.57 · 2024-06-18
    Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives

    Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives.

    🎭 Mr. Market's Mood

    Learn more →
    INTU
    FearGreed
    😨Fear(25/100)

    "Market is pessimistic — investigate whether fears are temporary or structural"

    Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.
    MRNA
    FearGreed
    😏Greed(61/100)

    "Market is optimistic — be cautious and ensure you have a margin of safety"

    Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

    Composite sentiment score based on market signals. Inspired by Buffett’s "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

    ⚖️ Buffett Signal

    Learn more →
    INTU
    Awaiting DCF Data

    The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

    DCF Margin of Safety: N/AMr. Market's Mood: Fear (25)
    MRNA
    Awaiting DCF Data

    The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

    DCF Margin of Safety: N/AMr. Market's Mood: Greed (61)
    View INTU Full AnalysisView MRNA Full Analysis

    Frequently Asked Questions: INTU vs MRNA

    Is Intuit Inc. or Moderna, Inc. more undervalued in 2026?

    Based on our discounted cash flow model, INTU trades at a 50.2% margin of safety (intrinsic value $536 vs. price $267), compared to MRNA's -962.8% margin of safety (intrinsic $6 vs. $64).

    Which stock has a wider economic moat, Intuit Inc. or Moderna, Inc.?

    INTU scores 79/100 (Wide moat), while MRNA scores 17/100 (None moat). The moat score measures competitive advantage durability across ROIC consistency, margin stability, revenue predictability, and reinvestment efficiency.

    Is Moderna, Inc. in financial distress?

    MRNA's Altman Z-Score of 2.5 places it in the Grey zone, signaling elevated bankruptcy risk. INTU scores 8.3 (Safe zone). The Altman Z-Score is a five-factor model that predicts insolvency within two years; scores below 1.81 indicate significant distress.

    Which company has better free cash flow, Intuit Inc. or Moderna, Inc.?

    Intuit Inc. (INTU) generates a 7.2% free cash flow yield, compared to Moderna, Inc.'s -0.1%. A higher FCF yield means the business converts more of its market value into cash that can be returned to shareholders or reinvested.

    Which stock has higher return on invested capital, Intuit Inc. or Moderna, Inc.?

    INTU earns 28.2% ROIC versus MRNA's -26.5%. A higher ROIC means the company generates more profit per dollar of capital employed, a hallmark of durable competitive advantage in Buffett-style analysis.

    INTU vs MRNA: Which Is the Better Buy in 2026? | SafetyMargin.io